Looking for positives.....
They are putting out revenue guidance of ~$14M per quarter.
The MedAdvisor board is confident with the progress of its Adheris integration and the opportunity that exists in the US market. As a result, MedAdvisor is providing full year FY21 revenue guidance of $38-39m, with gross margin percentage of approximately 55%. The Company is providing CY21 revenue guidance of $55-57m.
Some shakeup in the US Healthcare market with Cotiviti acquiring HMS. Getting the MedAdvisor name out there is hopefully a good move.
Following an increasing US profile and inbound interest, MedAdvisor has appointed US investment bank BTIG for a US non-deal roadshow in Q4.
https://www.btig.com/products-services/investment-banking/sectors/healthcare/
But I sense they need more cash. Let's hope it's above the previous price of 38c.
MedAdvisor is currently negotiating other funding arrangements to provide additional sources of capital, which it believes is highly likely to be successful. These negotiations are commercial in confidence.
Ann: Quarterly Report and Appendix 4C, page-3
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.010(4.17%) |
Mkt cap ! $137.8M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 24.0¢ | $14.98K | 61.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 59581 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50350 | 4 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |